‘As physicians, we emphasize more of the biology of the cancer often, especially with the recent concentrate on personalized medicine. But we need to spend the same focus on resources available to our patients, as this greatly impacts their probabilities to survive leukemia,’ study senior author Dr. Luciano Jose Costa, a co-employee professor at the University of Alabama at Birmingham , said in a journal news release. In conducting the study, researchers used a database of more than 5,500 people beneath the age of 65.The decline in mortality because of diabetes did not really relate to a lower life expectancy pre-transplant risk profile and was independent of post-transplant variables. The usage of cardioprotective medicines and glycemic control improved as time passes post-transplant. Furthermore, graft function and serum albumin improved as time passes, and these parameters linked to better survival. We had been really encouraged to find this gap improve therefore dramatically, says Dr. Cosio. Diabetics who undergo kidney transplantation can get outcomes equally as effective as nondiabetics, so long as they are diligent in their management of blood pressure, glucose, healthy pounds, and other factors that influence their kidney function and overall well-being.